ImmunoPrecise Antibodies Ltd logo

ImmunoPrecise Antibodies Ltd

C$ 6.78 (+6.77%) Oct 4
P/E:
At Loss
P/B:
2.54
Market Cap:
C$ 168.39M ($ 124.39M)
Enterprise V:
C$ 150.27M ($ 111.00M)
Volume:
19.70K
Avg Vol (2M):
14.60K
Also Trade In:
Volume:
19.70K
Market Cap C$:
168.39M
Market Cap $:
124.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
14.60K
Enterprise Value C$:
150.27M
Enterprise Value $:
111.00M
PB Ratio:
2.54
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 17.12
Equity-to-Asset 0.83
Debt-to-Equity 0.02
Debt-to-EBITDA -0.06
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.58
Distress
Grey
Safe
Beneish M-Score -1.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 77.35
9-Day RSI 63.05
14-Day RSI 56.95
6-1 Month Momentum % -2.97
12-1 Month Momentum % -8.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.06
Quick Ratio 4.77
Cash Ratio 3.59
Days Inventory 62.37
Days Sales Outstanding 47.27
Days Payable 144.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.7

Financials (Next Earnings Date:2022-12-13 Est.)

TSXV:IPA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 19.465
EPS (TTM) (C$) -1.07
Beta -0.04
Volatility % 61.72
14-Day RSI 56.95
14-Day ATR (C$) 0.4148
20-Day SMA (C$) 6.2585
12-1 Month Momentum % -8.52
52-Week Range (C$) 4.52 - 8.81
Shares Outstanding (Mil) 24.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmunoPrecise Antibodies Ltd Filings

Document Form Filing Date
No Filing Data

ImmunoPrecise Antibodies Ltd Analysis

Share your research